Mounjaro is a prescription medication that combines two active ingredients, tirzepatide and a GLP-1 receptor agonist, to help with weight loss and blood sugar management
Importantly, researchers observed improvements that could not be explained by weight loss alone, suggesting a potential direct anti-inflammatory or immune-modulating effect
Fasting with GLP-1 therapy requires medical oversight because these medications slow stomach emptying, and extended fasting can increase nausea risk or trigger low blood sugar
Its five concurrent mechanisms, telomere maintenance, epigenetic regulation, antioxidant defense, immune recalibration, and circadian restoration, address the underlying biology of aging from multiple angles in a single protocol